We are a UK-based company developing diagnostic and prognostic services for the in-vitro assessment of risk of dementias such as Alzheimer's disease.
We are currently developing laboratory services for proprietary blood-based assays in partnership with pharmaceutical companies, for investigational use in the evaluation of new drugs for dementias including Alzheimer's disease.
Our services are being developed to assist in the stratification of clinical trial subjects and enhance drug discovery and development trials.
Talk to Cytox
To find out more and discuss potential industry or academic collaboration please contact us by clicking here